Expansion At Genentech Inc.'s Headquarters

The Genentech headquarters sits in South San Francisco, California, U.S., on Monday, Dec. 21, 2009. Roche Holding AG's Genentech unit asked U.S. regulators to approve the use of the Lucentis medicine in patients with retinal vein occlusion, the Basel-based company said in an e-mailed statment. Photographer: Chip Chipman/Bloomberg via Getty Images
The Genentech headquarters sits in South San Francisco, California, U.S., on Monday, Dec. 21, 2009. Roche Holding AG's Genentech unit asked U.S. regulators to approve the use of the Lucentis medicine in patients with retinal vein occlusion, the Basel-based company said in an e-mailed statment. Photographer: Chip Chipman/Bloomberg via Getty Images
Expansion At Genentech Inc.'s Headquarters
PURCHASE A LICENCE
How can I use this image?
475.00 €
EUR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg’s prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
95012251
Collection:
Bloomberg
Date created:
22 December, 2009
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
GENENTECH HEADQUARTERS